Table 1.

Antimicrobial susceptibility testing of the three strains studied

StrainMIC (mg/L)
NALCIPNORERYCHLTETTMPAMPFOXCROKAN
Ty_wt2500.519640.50.0940.09410.0641
Ty_c110001812841.50.250.7540.1251
Ty_c22000824>25612840.7541280.51
StrainMIC (mg/L)
NALCIPNORERYCHLTETTMPAMPFOXCROKAN
Ty_wt2500.519640.50.0940.09410.0641
Ty_c110001812841.50.250.7540.1251
Ty_c22000824>25612840.7541280.51

NAL, nalidixic acid; CIP, ciprofloxacin; NOR, norfloxacin; ERY, erythromycin; CHL, chloramphenicol; TET, tetracycline; TMP, trimethoprim; AMP, ampicillin; FOX, cefoxitin; CRO, ceftriaxone; KAN, kanamycin.

Table 1.

Antimicrobial susceptibility testing of the three strains studied

StrainMIC (mg/L)
NALCIPNORERYCHLTETTMPAMPFOXCROKAN
Ty_wt2500.519640.50.0940.09410.0641
Ty_c110001812841.50.250.7540.1251
Ty_c22000824>25612840.7541280.51
StrainMIC (mg/L)
NALCIPNORERYCHLTETTMPAMPFOXCROKAN
Ty_wt2500.519640.50.0940.09410.0641
Ty_c110001812841.50.250.7540.1251
Ty_c22000824>25612840.7541280.51

NAL, nalidixic acid; CIP, ciprofloxacin; NOR, norfloxacin; ERY, erythromycin; CHL, chloramphenicol; TET, tetracycline; TMP, trimethoprim; AMP, ampicillin; FOX, cefoxitin; CRO, ceftriaxone; KAN, kanamycin.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close